Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies [Yahoo! Finance]
Aethlon Medical, Inc. (AEMD)
NASDAQ:AMEX Investor Relations:
ir.aethlonmedical.com
Company Research
Source: Yahoo! Finance
Interested Clinical Sites Have Initiated Submissions For Ethics Committee Review SAN DIEGO June 3, 2024 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today provided the following update on its planned phase 1 safety, feasibility and dose-finding clinical trials of its Hemopurifier ® in patients with solid tumors who have stable or progressive disease during anti-PD-1 monotherapy treatment, such as Keytruda ® or Opdivo ® "We continue to make progress preparing for our planned, safety, feasibility and "dose finding" oncology trials in Australia and India , and want to provide our shareholders and other constituents with an update, stated Steven LaRosa , MD, Chief Medical Officer of Aethlon Medical. In early May, we announced new data showing the in vitro removal of exosomes from cancer patient plasma using a miniature version of our Hemopurifier ® . This da
Show less
Read more
Impact Snapshot
Event Time:
AEMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AEMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AEMD alerts
High impacting Aethlon Medical, Inc. news events
Weekly update
A roundup of the hottest topics
AEMD
News
- Aethlon Medical, Inc. (NASDAQ: AEMD) had its price target lowered by analysts at HC Wainwright from $10.00 to $7.00. They now have a "buy" rating on the stock.MarketBeat
- Aethlon Medical, Inc. (NASDAQ: AEMD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024 [Yahoo! Finance]Yahoo! Finance
- Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024PR Newswire
- What's Next in Treatments for Cancer Patients with Solid Tumors? [Yahoo! Finance]Yahoo! Finance
AEMD
Earnings
- 2/14/24 - Miss
AEMD
Sec Filings
- 5/24/24 - Form 8-K
- 5/17/24 - Form 8-K
- 5/17/24 - Form EFFECT
- AEMD's page on the SEC website